E Stolk, J Busschbach. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Cost-Benefit AnalysisErectile Dysfunction/drug therapyErectile Dysfunction/economicsHumansMalePhosphodiesterase Inhibitors/economicsPhosphodiesterase Inhibitors/therapeutic usePiperazines/economicsPiperazines/therapeutic usePoliticsPurinesQuality-Adjusted Life YearsSildenafil CitrateSulfones
Substances: See more » Phosphodiesterase InhibitorsPiperazinesPurinesSulfonesSildenafil Citrate
Year: 2000 PMID: 11012253 PMCID: PMC1118399
Source DB: PubMed Journal: BMJ ISSN: 0959-8138